Patent Classification

1. Ketosis-treating agent

Treatment, Kaposi's Sarcoma

1. Treatment of Kaposi's sarcoma with IL-12
    
2. Treatment of Kaposi's sarcoma with IL-12
    
3. Genes of kaposi's sarcoma associated herpesvirus

Treatment, Kidney/Renal Diseases

1. Methods for the treatment of nephro-disorders using aminothiol compounds
    
2. Gene encoding organic anion transporter
    
3. Method of administration of a nutritional product to a person having renal failure
    
   
4. Methods and composition for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells

1. Memory loss treatment formulation
    
2. Learning and short term memory defects with Neurofibromatosis 1 (NF1) expression

1. Control of protozoa and protozoan cysts that harbor legionella

Treatment, Leishmaniosis

1. Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
    
2. Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
    
3. Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained

Treatment, Leptospirosis

1. Leptospira vaccine antigens for the prevention of Leptospirosis

Treatment, Leukemia

1. Antibodies that bind the cytokine designated LERK-5
    
2. Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cell
    
3. Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors
    
4. Purging leukemia cells from hematopoietic stem cells
    
5. Serum-derived factor inducing cell differentiation and medical uses thereof
   
   
6. CML Therapy
   
   
7. Combination therapy for lymphoproliferative diseases
    
8. Method of inducing apoptosis in cancer cells using an extract of Melothria indica Lou

1. Formulations for controlling human lice

1. Interventions to mimic the effects of calorie restriction

1. 18891, a novel human lipase

1. L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage

Treatment, Lung Cancer

1. Compounds and methods for therapy and diagnosis of lung cancer
    
2. Compounds and methods for therapy and diagnosis of lung cancer

1. Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
    
2. Treatment of lupus erythematosus

Treatment, Lyme Disease

1. Method for treatment of lyme disease
    
2. Immunologically active proteins from Borrelia burgdorferi
    
3. VMP-like sequences of pathogenic borrelia
    
4. Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides

Treatment, Lymphedema

1. Method for the treatment of lymphedema using guaifenesin

Treatment, Lymphomas

1. Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomas

Treatment, Lysosomal Storage Diseases

1. Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
    
2. Methods of treating lysosomal storage diseases

Treatment, Malaria

1. Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems
    
2. Malaria vaccine
    
3. Polypeptides and DNA encoding same
    
4. Malaria merozoite antigen subunit vaccine
    
5. Combination preparation for treating malaria

Treatment, Measles

1. Gene coding for the measles virus mutant antigen

Treatment, Meningitis

1. Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
    
2. Therapeutic uses of BPI protein products for human meningococcemia
    
3. Invasion associated genes from Neisseria meningitidis serogroup B
    
4. Methods of immunizing adults using anti-meningococcal vaccine compositions
    
5. Antibodies to meningococcal polysaccharide conjugate vaccines

Treatment, Menopause Related Disorders

1. Ovariectomized mouse model for human menopause
    
2. Method for the treatment of symptoms related to normal hormonal variations in women
    
3. Formulation for menopausal women
    
4. Herbal supplement for cognitive related impairment due to estrogen loss

Treatment, Metabolic Disorders

1. Acceleration of the rate of digestion of a protein
    
2. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
    
3. Method of preventing development of severe metabolic derangement in inborn errors of metabolism

Treatment, Migraine

1. Formulations and methods for treating chronic migraine
    
2. Treatment of migraine headache
    
3. Composition for the treatment of migraine
    
4. Use of valproic acid analog for the treatment and prevention of migraine and affective illness

Treatment, Mood Disorders

1. Anti-depressant, stress suppressor and mood improver
   
   
2. Composition for controlling mood disorders in healthy individuals

Treatment, Motion Sickness

1. Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity

Treatment, Mucositis/Mucous Membrane Related Disorders

1. Methods and compositions for treating pain of the mucous membrane
    
2. Methods and compositions for treating and preventing mucositis

Treatment, Multiple Diseases/Miscellaneous Diseases

1. Therapeutic inhibitor of vascular smooth muscle cells
    
2. Mutant having uracil phosphoribosyl transferase activity
    
3. Anti-.alpha.v.beta.3 recombinant human antibodies, nucleic acids encoding same
    
4. FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
    
5. Memory loss treatment formulation
    
6. Monoamine oxidase (MAO) inhibitors and uses thereof
    
7. Vaccine compositions for mucosal delivery
    
8. Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
    
9. Artificial proteoglycans
    
10. Oncogene-induced apoptosis in drug-resistant cells
     
11. Methods for treating cell death diseases and inflammation
     
12. Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
     
13. Acceleration of the rate of digestion of a protein
     
14. Synthetic endogenous cannabinoids analogues and uses thereof
     
15. Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
     
16. Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin
     
17. Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract
     
18. Human thyroid protein ZSIG45
     
19. Method of stimulating an immune response with activated dendritic cells
     
20. Multimeric immunotoxins
     
21. Antioxidant activity in SDG metabolites
     
22. Mixture of primary fatty acids obtained from sugar cane wax
     
23. Devices for the delivery of drugs having antiprogestinic properties
     
24. Topical and oral delivery of arginine to cause beneficial effects
     
25. Therapeutic using a bispecific antibody
     
26. Purposeful movement of human migratory cells away from an agent source
     
27. Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same
     
28. Specific pancreatic lipase inhibitors and their applications
     
29. Keratinocyte derived interferon
     
30. Death domain containing receptor-4
     
31. Method and compositions for increasing intestinal absorption of fats
     
32. Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
     
33. Method for judging effectiveness of drug having protease inhibitory activity
     
34. Double capsule for the administration of active principles in multiple therapies
    
    
35. Retroinverso polypeptides that mimic or inhibit thrombospondin activity
     
    
36. Method of preventing neuronal death
     
    
37. Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
     
    
38. Product and method reduce stress induced immune suppression
     
    
39. Insulin-like growth factor agonist molecules
     
    
40. Medicament comprising HGF gene
     
    
41. Regulation of cytokine synthesis and release
     
    
42. Topical and oral delivery of arginine to cause beneficial effects

Treatment, Multiple Myeloma

1. Peptides binding to bone marrow stromal cell antigen

Treatment, Multiple Sclerosis

1. Method of treating multiple sclerosis
    
2. Inhibiting MOG-antibody binding
    
3. Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tyrptophan and possibly a vitamin B12 compound
    
4. Treatment of demyelinating autoimmune disease with ordered peptides
    
5. Treatment of fatigue, head injury and stroke
    
6. Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
   
   
7. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
   
   
8. Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
    
   
9. DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis
    
   
10. Method for treatment of multiple sclerosis and related disease states
     
    
11. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
     
    
12. Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients

1. Pharmaceutical composition for muscular anabolism

Treatment, Mycobacterial Infection

1. Vaccine against mycobacterial infections

Treatment, Myocardial Infarction

1. Composition for the treatment and prevention of endothelial dysfunction
    
2. Method for the prevention of apoptosis

Treatment, Neural Regeneration

1. Production of gabaergic cells
    
2. Methods of inducing nervous tissue regeneration
    
3. Use of prosaposin and peptides obtained therefrom for treatment of neural degeneration
    
4. Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF
    
5. Promoters of neural regeneration

Treatment, Neurological Disorders/Injuries

1. Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
    
2. Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
    
3. Production of gabaergic cells
    
4. Prevention and treatment of amyloid-associated disorders
    
5. Method of detecting axonally-derived protein tau in patients with traumatic CNS injury
    
6. Polyamine treatment of neurological disorders
    
7. Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate
    
8. Method of stable integration of DNA into neurons
    
9. Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF
    
10. Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration
     
11. Chimeric toxins
     
12. Methods for using elk-L to enhance neuronal survival
     
13. Immunological agents specific for prion protein (PRP)
     
14. Using glutathiane to protect neurons from injury
     
15. Human metabotropic glutamate receptor 7 subtypes
     
16. Method of preparing and using compositions extracted from vegetable matter for the treatment of neurological conditions
     
17. Nerve regeneration
     
18. Treatment of cerebral disorders by inhibition of IL-8 binding to receptor
     
19. Pharmacotherapeutic process and composition for central nervous system disorders
     
20. Laser inactivation of inhibitory molecules in central nervous system myelin
     
21. Facilitation of repair of neural injury with CM101/GBS toxin
     
22. Method for aiding cerebral recovery following neurodegeneration
     
23. Method for increasing the concentration of ascorbic acid in brain tissue of a subject
     
24. Method of promoting synthesis of nerve growth factor
    
    
25. ARPE-19 as a platform cell line for encapsulated cell-based delivery
    
    
26. Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
    
    
27. Semaphorin-specific antibodies
    
    
28. Method for administering fibroblast growth factor to the brain 
    
    
29. Method of preventing neuronal death
     
    
30. Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
     
    
31. Method for improving delivery of tyrosine supplementation
     
    
32. Beverage containing caffeine or theobromine and vinpocetine citrate for stimulating cerebral activity
     
    
33. Use of kinase inhibitors for treating neurodegenerative diseases
     
    
34. Method for generating dopaminergic cells derived from neural precursors
     
    
35. Protection against traumatic brain injury
     
    
36. Method for determining the prognosis of a patient with a neurological disease
     
    
37. Composition and method for repairing neurological tissue
     
    
38. Methods for treating neuropsychiatric disorders
     
    
39. Method for increasing the concentration of ascorbic acid in brain tissues of a subject
     
    
40. Method of using hedgehog polypeptides to regulate neuronal cell growth
     
    
41. Method for administering neurologic agents to the brain
     
    
42. Non-transgenic rodent model of alzheimer's disease

1. Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF
    
2. Biodegradable botulinum toxin implant
    
3. Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
    
4. Method for increasing the bioavailability of metaxalone
   
   
5. Use for pain management
   
   
6. Biodegradable neurotoxin implant
   
   
7. Method for treating dystonia with botulinum toxin types C to G
    
   
8. Botulinum toxin implant

1. Composition comprising a tramadol material and an anticonvulsant drug
    
2. Percutaneously applicable preparation and suppository containing an antidementia medicament
    
3. Methods for improving brain function using leptin or analogs thereof
    
4. Nutritional system for nervous system disorders
   
   
5. Treatments for nervous disorders
   
   
6. Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

1. Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
    
2. Reboxetine for treatment obsessive compulsive disorders and panic disorder
   
   
3. Methods of treating obsessive-compulsive spectrum disorders

1. System and method for treating eye and nerve diseases in diabetic and non-diabetic patients
    
2. Reconstructed laminae of human epithelium corneae and method of producing the same
    
3. Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
    
4. Topical treatment or prevention of ocular infections
    
5. Compositions and methods for treating eye discomfort
    
6. Use of nerve growth factor for the storage, culture or treatment of cornea
    
7. Compositions and methods for treating hyperimmune response in the eye
    
8. Treatment of dry eye syndrome
    
9. Intraocular transplantation of encapsulated cells
    
10. Anti-inflammatory eye drop
     
11. Methods and pharmaceutical compositions for the closure of retinal breaks
     
12. Method for treating meibomian gland disease
     
13. Methods and compositions for the treatment of keratoconus using protease inhibitors
     
14. Selective and non-invasive visualization or treatment of vasculature
     
15. Composition for treatment of an ocular bacterial infection
    
    
16. Histochrome and its therapeutic use in ophthalmology
    
    
17. Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma
     
    
18. Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
     
    
19. Method for treating ophthalmic disease through fast dispersing dosage forms
     
    
20. Composition for treating dry eye
     
    
21. Ocular gene therapy
     
    
22. Drug composition comprising albumin as active ingredient

1. Method for improving bone mineralization
    
2. Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo
    
3. Treatment of subnormal bone mineral density
    
4. Method for induction of differentiation of osteoclasts
    
5. Osteoclast secreted chemokine and uses thereof
    
6. Diagnostics and therapeutics for osteoporosis
    
7. Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells
    
8. Nasal calcitonin formulations
    
9. Agent for anti-osteoporosis
    
10. Modified human parathyroid hormone
     
11. Methods for inhibiting bone resorption
     
12. Treatment of skeletal disorders
    
    
13. Treatment or prevention of osteoporosis
     
    
14. Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome
     
    
15. Parathyroid hormone analogues for the treatment of osteoporosis
     
    
16. Treatment of conditions associated with impairment in the level of the parathyroid hormone

1. Compounds from moraxella catarrhalis
    
2. Composition and method for treatment of otitis media

Treatment, Ovarian Carcinoma

1. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
    
2. Compositions and methods for therapy and diagnosis of ovarian cancer
    
3. Compositions and methods for therapy and diagnosis of ovarian cancer
    
4. Sustained GnRH peptide-release formulation
    
   
5. Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof

1. Active oxygen scavenger and cancer chemopreventer from Grifola
    
2. Dendrimer constructs and metal complexes thereof having superoxide dismutase activity

1. Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo

Treatment, Pain/Analgesic/Anesthetic

1. Use for pain management
    
2. Method for alleviating pain or providing an analgesic effect in a patient
    
3. Analgesics combined with naturally-occurring chondroprotective agents
    
4. Analgesic regimen
    
5. Method of local anesthesia and analgesia
    
6. Method for treatment of pain
    
7. Method for preventing or treating pain by administering an endothelin antagonist
    
8. Prolonged anesthesia in joints and body spaces
    
9. Formulations and methods for providing prolonged local anesthesia
    
10. Methods and compositions for treating pain of the mucous membrane
     
11. Clostridial toxin derivatives and methods for treating pain
     
12. Analgesic screening method and composition
     
13. Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold
     
14. Method for treating pain by peripheral administration of a neurotoxin
     
15. Compositions and methods comprising morphine gluconate
     
16. Transplantation of neural cells for the treatment of chronic pain or spasticity
     
17. Process and composition for temporarily suppressing pain
     
18. Formulations and methods for providing prolonged local anesthesia
     
19. Triple drug therapy for the treatment and prevention of acute or chronic pain
     
20. Topical dermal anaesthetic
     
21. Use of conantokins for producing analgesia or for neuoprotection
    
    
22. Use for pain management
    
    
23. Opioid agonist/opioid antagonist/acetaminophen combinations
    
    
24. Use of inhibitors of protein kinase C epsilon to treat pain
    
    
25. Intraspinal botulinum toxin for treating pain
    
    
26. Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
    
    
27. Analgesic use of podophyllotoxin for treating pain conditions in female genital organs
    
    
28. System for percutaneous delivery of opioid analgesics
    
    
29. Pain relief preparation for use while bathing
    
    
30. Analgesic regimen
     
    
31. Pharmaceutical formulations comprising vegetal material selected from trichilia 
     
32. Therapeutic compositions for intranasal administration which include KETOROLAC.RTM.
     
    
33. Preemptive analgesic agent and methods of use
     
    
34. Clear, injectable formulation of an anesthetic compound
     
    
35. Herbal composition to relieve pain
     
    
36. Mu-opiate receptor peptides
     
    
37. Enhanced transdermal anesthesia of local anesthetic agents
     
    
38. Methods and apparatus for improved administration of fentanyl and sufentanil
     
    
39. Topical anesthetic patch
     
    
40. Administration of ketamine to manage pain and to reduce drug dependency
     
    
41. Composition of S-sodium ibuprofen
     
    
42. High load formulations and methods for providing prolonged local anesthesia
     
    
43. Intraspinal methods for treating pain
     
    
44. Biodegradable polymer matrices for sustained delivery of local anesthetic agents
     
    
45. Use of antidepressants for local analgesia

1. Method of treating cancer with anti-neurotrophin agents
    
2. Methods of culturing and encapsulating pancreatic islet cells
   
   
3. Method for treating a pancreatic disorder with a neurotoxin
    
   
4. Immobilization of lipases by entrapment in silica matrices

1. Reboxetine for treatment obsessive compulsive disorders and panic disorder

1. Antiparasitic helminth larval thiol specific antioxidant-antibodies, and uses thereof
    
2. Spot-on formulations for combating parasites
    
3. Parasitic nematode transglutaminase proteins and uses thereof
   
   
4. Parasitic helminth DiAg2 proteins and uses thereof

1. Stabilized thyroxine compounds
    
2. Method for treating hypothyroidism
    
3. Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
    
4. Human thyroid protein ZSIG45
    
5. Antibodies and methods of making antibodies to human thyroid protein zsig45
    
6. Liquid pharmaceutical compositions comprising thyroid hormones
    
7. Modified human parathyroid hormone
    
8. Parathyroid hormone-related peptide analogs
   
   
9. Method for treating Hashimoto's thyroiditis
   
   
10. Method for treating hyperparathyroidism

1. Parkinson's disease treatment
    
2. Pulmonary delivery in treating disorders of the central nervous system
    
3. Therapeutic uses of melatonin
    
4. Therapeutic Gene
    
5. Pulmonary delivery in treating disorders of the central nervous system
    
6. Vesicular monoamine transporter gene therapy in Parkinson's disease
    
7. Method for increasing the concentration of ascorbic acid in brain tissue of a subject
    
8. Treatment of dyskinesias and Parkinson's disease with riluzole and levodopa
    
9. Combinations of riluzole and levodopa for the treatment of Parkinson's disease
   
   
10. Method for treatment of a neurological disease characterized by impaired neuromodulator function
    
    
11. Method of controlling L-Dopa production and of treating dopamine deficiency
     
    
12. Method for treating parkinson's disease with a botulinum toxin
     
    
13. Method for generating dopaminergic cells derived from neural precursors
     
    
14. Methods for treating Parkinson's disease using optically pure (-)-bupropion
     
    
15. Intestinal absorption of nicotine to treat nicotine responsive conditions
     
    
16. Methods and apparatus for treatment of Parkinson's disease

1. Providing patient-specific drug information

1. Phytodrug for management of peptic ulcer and methods of preparing and using same
   
   
2. Chinese drug composition for treatment of peptic ulcer and preparation thereof

1. Antibiotic/medicated gutta percha point
    
2. Animal model for detection of vulnerable plaques
    
3. Enzyme capable of hydorlyzing plaque, microorganism producing the same, and a composition comprising the same
    
4. Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
    
5. Topical dermal anaesthetic
    
6. Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth
    
   
7. Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase A2
    
   
8. Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof

1. Composition and method for treating peyronie's disease and related fibrotic tissue disorders

Treatment, Phenylketonuria

1. Nutritional formula for phenylketonuria patients

Treatment, Photodynamic Therapy

1. Composition and method for causing photodynamic damage to target cells

Treatment, Polycystic Ovarian Disease

1. Kit for use in treatment of polycystic ovarian disease

Treatment, Prematurely Born Neonate

1. Method of preventing retinopathy of prematurity in a neonate

1. Diagnosis of pre-eclampsia
    
2. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
    
3. Endometrial function
    
4. Methods and compositions for the selective regulation of chorionic prostanoids
    
5. Repair of ruptured membrane by injection of naturally occurring protein in amniotic fluid sac

1. Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms
    
2. PMS defense: an aromatherapy compound for the relief of symptoms of premenstrual syndrome
    
   
3. Method for treating symptoms associated with premenstrual syndrome by administering a combination of calcium and vitamin D

1. Probiotic therapy for newborns

Treatment, Progestin Therapy

1. Progestin therapy for maintaining amenorrhea

Treatment, Prostate Cancer/Hypertrophy

1. Compounds for immunotherapy of prostate cancer and methods for their use
    
2. Use of a Serenoa repens extract for the production of a medicament to treat prostate cancer
    
3. Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
    
4. Method of treating cancer with anti-neurotrophin agents
    
5. Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
    
6. Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
    
7. Use of garlic extract as both preventive and therapeutic agents for human prostate and bladder cancers
    
8. Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
   
   
9. Uteroglobin gene therapy for epithelial cell cancer
   
   
10. Method of treating cancer of the prostate
    
    
11. Mice models of human prostate cancer progression
    
    
12. Sustained GnRH peptide-release formulation
     
    
13. Method of inducing apoptosis in cancer cells using an extract of Melothria indica Lou
     
    
14. Composition for treating benign prostatic hypertrophy
     
    
15. Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen
     
    
16. Prostate cancer gene
     
    
17. Compounds for immunotherapy of prostate cancer and methods for their use

1. Anti-protozoan methods and materials

1. Pseudomonas treatment composition and method

1. Topical composition for the treatment of psoriasis and related skin disorders
    
2. Animal model for psoriasis for the prevention and treatment of psoriasis in humans
   
   
3. Chinese herbs extract
   
   
4. Topical medicament for the treatment of psoriasis
   
   
5. Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis
   
   
6. Methods and compositions for the treatment of psoriasis

1. Use of molindone to treat oppositional defiant disorder and conduct disorder
    
2. Quetiapine granules
    
3. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
    
4. Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same
    
5. Cleavage system inhibitors as potential antipsychotics
   
   
6. Method and devices for transdermal delivery of lithium
   
   
7. Glycine substitutes and precursors for treating a psychosis
   
   
8. Adhesive patch for lithium controlled release

Treatment, Pulmonary Disorders

1. Preventing airway mucus production by administration of EGF-R antagonists
    
2. Therapies for treating pulmonary diseases
    
3. Expression of cloned genes in the lung by aerosol and liposome-based delivery

Treatment, Radiation Toxicity

1. Method for reducing radiation toxicity